Evidence mapPaperPMID 41422332Full record

ArticleScientific reports2025

Salivary short chain fatty acids serve as biomarkers of periodontal inflammatory burden.

Kazu Takeuchi-Hatanaka, Yasushi Shirahase, Toshiyuki Yoshida, Mari Kono, Naoki Toya, Kenji Konishi, Kazuhiro Omori, Shogo Takashiba

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Periodontal health and disease.Scientific reports · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kazu Takeuchi-HatanakaDivision of Periodontics and Endodontics, Department of Dentistry, Okayama University Hospital, Okayama, Japan.
Yasushi ShirahaseSysmex Corporation, Kobe, Japan.
Toshiyuki YoshidaSysmex Corporation, Kobe, Japan.
Mari KonoSysmex Corporation, Kobe, Japan.
Naoki ToyaSysmex Corporation, Kobe, Japan.
Kenji KonishiDiagnostics Division, IVD Enzyme Department, Asahi Kasei Pharma Corporation, Shizuoka, Japan.
Kazuhiro OmoriDepartment of Pathophysiology-Periodontal Science, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, 700-8525, Japan.
Shogo TakashibaDepartment of Pathophysiology-Periodontal Science, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, 700-8525, Japan. stakashi@okayama-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periodontitis is a chronic inflammatory condition associated with systemic diseases. Early detection and intervention are crucial; however, conventional diagnostic methods require specialized dental procedures. Therefore, we aimed to develop a noninvasive saliva-based screening method that can be easily performed outside dental clinics. This cross-sectional pilot study evaluated three periodontal indices-probing depth, Periodontal Inflamed Surface Area (PISA), and periodontal epithelial surface area-in relation to short-chain fatty acids (SCFAs) and bacterial profiles in the saliva. Saliva samples collected during the day exhibited stronger correlations with periodontal indices than waking time samples, demonstrating a significant association with periodontal pathogens, protease activity, and elevated levels of butyric acid. The diagnostic thresholds for PISA were 300 mm

Indexed as

BiomarkersFatty Acids, VolatilePeriodontitisSalivaAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedPeriodontal IndexPilot ProjectsBiomarkersFatty Acids, VolatileCross-sectional studiesPeriodontal inflamed surface areaPeriodontitisSalivaScreeningShort-chain fatty acid

Identifiers

PMID41422332
PMCPMC12804189

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.